Capmatinib in patients with METex14-mutated or high-level MET-amplified advanced non-small-cell lung cancer (NSCLC): results from cohort 6 of the phase 2 GEOMETRY mono-1 study.

Groen, H. J. M., Akerley, W. L., Souquet, P. J., Laack, E., Han, J-Y., Smit, E. F., Mansfield, A. S., Garon, E. B., Wolf, J., Tan, D. S-W., Heist, R. S., Waldron-Lynch, M., Le Mouhaer, S., Nwana, N., Giovannini, M. & Orlov, S., 20-May-2020, In : Journal of Clinical Oncology. 38, 15, 2 p.

Research output: Contribution to journalMeeting AbstractAcademic

  • Harry J. M. Groen
  • Wallace L. Akerley
  • Pierre Jean Souquet
  • Eckart Laack
  • Ji-Youn Han
  • Egbert F. Smit
  • Aaron Scott Mansfield
  • Edward B. Garon
  • Juergen Wolf
  • Daniel Shao-Weng Tan
  • Rebecca Suk Heist
  • Maeve Waldron-Lynch
  • Sylvie Le Mouhaer
  • Ngozi Nwana
  • Monica Giovannini
  • Sergey Orlov
Original languageEnglish
Number of pages2
JournalJournal of Clinical Oncology
Issue number15
Publication statusPublished - 20-May-2020

ID: 136156607